{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:46:01Z","timestamp":1793324761332,"version":"4.5.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2005,8,23]]},"abstract":"<jats:p>\n                    <jats:bold>\n                      <jats:italic>Background\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    Secondary erythrocytosis results in increased shear stress in cyanotic congenital heart disease (CCHD), which may modify the balance between vasodilators and vasoconstrictors and affect systemic endothelial function. Because no data are available on systemic vasomotion, systemic endothelial function and nitric oxide (NO) availability were investigated in CCHD patients.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>\n                      <jats:italic>Methods and Results\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    Responses to arterial endothelium-dependent (acetylcholine [Ach]) and -independent (sodium nitroprusside [SNP]) vasodilation, NO synthase blockade (\n                    <jats:italic>N<\/jats:italic>\n                    <jats:sup>G<\/jats:sup>\n                    -monomethyl-\n                    <jats:sc>l<\/jats:sc>\n                    -arginine [\n                    <jats:sc>l<\/jats:sc>\n                    -NMMA]), endothelin-1 (ET-1), and ET-1 receptor blockade by BQ-123 in 11 CCHD patients (O\n                    <jats:sub>2<\/jats:sub>\n                    saturation &lt;90%; mean\u00b1SD, 79\u00b11%; mean\u00b1SD age, 39\u00b12 years) were compared with those in 10 age-matched healthy referents by using forearm venous occlusion plethysmography. Resting forearm blood flow (FBF) was lower in CCHD patients than in referents (2.4\u00b10.2 versus 3.5\u00b10.4 mL \u00b7 min\n                    <jats:sup>\u22121<\/jats:sup>\n                    \u00b7 100 mL\n                    <jats:sup>\u22121<\/jats:sup>\n                    of forearm volume [FAV],\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.05). Although the response to SNP was similar in both groups (CCHD, 2.0\u00b10.3 to 8.3\u00b11.0; referents, 3.6\u00b10.7 to 11.9\u00b11.2 mL \u00b7 min\n                    <jats:sup>\u22121<\/jats:sup>\n                    \u00b7 100 mL\n                    <jats:sup>\u22121<\/jats:sup>\n                    of FAV;\n                    <jats:italic>P<\/jats:italic>\n                    &gt;0.1), the response to Ach was markedly reduced in CCHD (maximal increase in FBF, 2.8\u00b10.8 versus 37.5\u00b14.4 mL \u00b7 min\n                    <jats:sup>\u22121<\/jats:sup>\n                    \u00b7 100 mL\n                    <jats:sup>\u22121<\/jats:sup>\n                    of FAV;\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.0001).\n                    <jats:sc>l<\/jats:sc>\n                    -NMMA was less effective in CCHD (decrease in FBF, 25\u00b16% versus 40\u00b14%;\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.05). ET-1 caused less vasoconstriction in the CCHD group (\u221225\u00b19% versus \u221251\u00b17%,\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.05), but the response to BQ-123 was similar in both groups (32\u00b19% versus 27\u00b19%).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>\n                      <jats:italic>Conclusions\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    Systemic endothelial dysfunction is evident in CCHD patients as shown by strikingly reduced endothelial vasodilation to Ach. The response to exogenous ET-1 is reduced, possibly because of elevated endogenous ET-1 levels, but the effects of endogenous ET-1 on arterial tone are not enhanced, as indicated by the similar response to ET-1 blockade.\n                  <\/jats:p>","DOI":"10.1161\/circulationaha.105.534073","type":"journal-article","created":{"date-parts":[[2005,8,15]],"date-time":"2005-08-15T20:25:39Z","timestamp":1124137539000},"page":"1106-1112","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":101,"title":["Systemic Endothelial Dysfunction in Adults With Cyanotic Congenital Heart Disease"],"prefix":"10.1161","volume":"112","author":[{"given":"Erwin","family":"Oechslin","sequence":"first","affiliation":[{"name":"From the CardioVascular Center (E.O., W.K., R.S., A.B., B.J., H.P.B.-L.R.), Division of Cardiology, University Hospital, Zurich, and the CardioVascular Center (W.K.), Klinik im Park, Zurich, and the Division of Cardiology (R.S., A.B., H.P.B.-L.R.), University Hospital, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Kiowski","sequence":"additional","affiliation":[{"name":"From the CardioVascular Center (E.O., W.K., R.S., A.B., B.J., H.P.B.-L.R.), Division of Cardiology, University Hospital, Zurich, and the CardioVascular Center (W.K.), Klinik im Park, Zurich, and the Division of Cardiology (R.S., A.B., H.P.B.-L.R.), University Hospital, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Schindler","sequence":"additional","affiliation":[{"name":"From the CardioVascular Center (E.O., W.K., R.S., A.B., B.J., H.P.B.-L.R.), Division of Cardiology, University Hospital, Zurich, and the CardioVascular Center (W.K.), Klinik im Park, Zurich, and the Division of Cardiology (R.S., A.B., H.P.B.-L.R.), University Hospital, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Bernheim","sequence":"additional","affiliation":[{"name":"From the CardioVascular Center (E.O., W.K., R.S., A.B., B.J., H.P.B.-L.R.), Division of Cardiology, University Hospital, Zurich, and the CardioVascular Center (W.K.), Klinik im Park, Zurich, and the Division of Cardiology (R.S., A.B., H.P.B.-L.R.), University Hospital, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Julius","sequence":"additional","affiliation":[{"name":"From the CardioVascular Center (E.O., W.K., R.S., A.B., B.J., H.P.B.-L.R.), Division of Cardiology, University Hospital, Zurich, and the CardioVascular Center (W.K.), Klinik im Park, Zurich, and the Division of Cardiology (R.S., A.B., H.P.B.-L.R.), University Hospital, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Peter","family":"Brunner-La Rocca","sequence":"additional","affiliation":[{"name":"From the CardioVascular Center (E.O., W.K., R.S., A.B., B.J., H.P.B.-L.R.), Division of Cardiology, University Hospital, Zurich, and the CardioVascular Center (W.K.), Klinik im Park, Zurich, and the Division of Cardiology (R.S., A.B., H.P.B.-L.R.), University Hospital, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.17.2.187"},{"key":"e_1_3_2_2_2","first-page":"99","volume":"50","year":"1998","unstructured":"Jia B, Zhang S, Chen Z, Li Z, Li X, Hui W, Ye M. Plasma endothelin 1 concentrations in children with congenital heart defects. Minerva Pediatr. 1998; 50: 99\u2013103.","journal-title":"Minerva Pediatr"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(99)00062-5"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.1999.03029.x"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1997.273.6.H2558"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.24.14367"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199507273330403"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199807)185:3<313::AID-PATH93>3.0.CO;2-8"},{"key":"e_1_3_2_9_2","first-page":"H806","volume":"272","year":"1997","unstructured":"Resta TC, Gonzales RJ, Dail WG, Sanders TC, Walker BR. Selective upregulation of arterial endothelial nitric oxide synthase in pulmonary hypertension. Am J Physiol. 1997; 272: H806\u2013H813.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1998.275.5.H1643"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.163.6.9908137"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.81.6.2344673"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(97)00074-3"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.103.18.2272"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.1999.02992.x"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.7.6.8472891"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041460103"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03092.x"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.5.9702061"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0296fje"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(98)70278-8"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.87.2.8425291"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-200208000-00016"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.95.2.357"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(97)00039-4"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.1999.069"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)41966-7"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(96)00196-9"},{"key":"e_1_3_2_29_2","first-page":"326","volume":"292","year":"2000","unstructured":"O\u2019Byrne S, Shirodaria C, Millar T, Stevens C, Blake D, Benjamin N. Inhibition of platelet aggregation with glyceryl trinitrate and xanthine oxidoreductase. J Pharmacol Exp Ther. 2000; 292: 326\u2013330.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.104.2.191"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000143378.58099.8c"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000025404.78001.d8"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2004.08.018"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0306-5251.2001.01495.x"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200501000-00004"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCULATIONAHA.105.534073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:41:03Z","timestamp":1715560863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.105.534073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,23]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8,23]]}},"alternative-id":["10.1161\/CIRCULATIONAHA.105.534073"],"URL":"https:\/\/doi.org\/10.1161\/circulationaha.105.534073","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,23]]},"assertion":[{"value":"2005-08-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}